|
Status |
Public on Dec 25, 2023 |
Title |
FluVax6 |
Sample type |
RNA |
|
|
Source name |
Tumor Tissue
|
Organism |
Mus musculus |
Characteristics |
fluvax treatment: Treated strain: Balb/c gender: Female age: Adult
|
Treatment protocol |
Intratumoral influenza vaccine administration
|
Growth protocol |
Tumor induced in vivo with 200,000 4T1 cells in mammary fat pad
|
Extracted molecule |
total RNA |
Extraction protocol |
RNA was extracted using the RNeasy Plus Mini Kit from tumor tissues. RNA was evaluated by Bioanalyzer
|
Label |
N/A
|
Label protocol |
Nanostring Murine Immune Exhaustion Kit Protocol
|
|
|
Hybridization protocol |
Nanostring Murine Immune Exhaustion Kit Protocol
|
Scan protocol |
nCounter Digital Analyzer
|
Data processing |
ROSALIND webtool software normalized using house keeping genes
|
|
|
Submission date |
Dec 21, 2023 |
Last update date |
Dec 25, 2023 |
Contact name |
Amanda Marzo |
Organization name |
Rush University
|
Street address |
1620 W Harrison St
|
City |
Chicago |
State/province |
IL |
ZIP/Postal code |
60612 |
Country |
USA |
|
|
Platform ID |
GPL32487 |
Series (1) |
GSE251825 |
nCounter mouse immune exhaustion panel in 4t1 breast cancer treated with repeat intratumoral influenza vaccine |
|